Informal consultation on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis - 1 May 2020
1 May 2020
| Publication

Overview
Agenda items
- Meeting agenda and Goal (Chair)
- Proposed way forward for generating evidence and scope of the core Data Monitoring committee (WHO, Tom Fleming)
- MRI data and statistical platform (BMGF)
- Current landscape and progress update for PrEP studies (BMGF, Principal Investigators)
- Current landscape and progress update for PEP studies (BMGF, Principal Investigators)
- Progress update for Core PrEP and PEP protocols (WHO, Ira Longini)
- AOB and action points
All consultations on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis
WHO Team
R&D Blue Print (RDB)
Number of pages
9